Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Potter

Showing results (221-230 of 257) with videos related to

Pageof 26
Sort By:
Leukemia & Lymphoma|November 17, 2006
The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide - vincristine - doxorubicin - methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysisPing Wu, Faith E Davies, Clive Horton, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2011
Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysisParameswaran Anoop, Bronwen E Shaw, Unell Riley, et al.
Contemporary Clinical Trials|July 27, 2021
The mobile assistance for regulating smoking (MARS) micro-randomized trial design protocolInbal Nahum-Shani, Lindsey N Potter, Cho Y Lam, et al.
The Journal of Infectious Diseases|March 7, 2006
Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosisDuncan A Clark, Elisabeth P Nacheva, Hoe Nam Leong, et al.
Clinical Transplantation|January 3, 2013
High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHDFiona L Dignan, Mike N Potter, Mark E Ethell, et al.
Oncogene|August 23, 2006
Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cellsB M Pickering, S de Mel, M Lee, et al.
British Journal of Haematology|May 27, 2005
Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatmentsCaroline L Alvares, Faith E Davies, Clive Horton, et al.
British Journal of Haematology|March 9, 2011
Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host diseaseBronwen E Shaw, Jane F Apperley, Nigel H Russell, et al.
Bone Marrow Transplantation|January 16, 2013
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation studyP G Medd, A J Peniket, T J Littlewood, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 24, 2007
N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacyCécile Béguin, David N Potter, Jennifer A Dinieri, et al.
Pageof 26

Showing results (221-230 of 257) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|November 17, 2006
The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide - vincristine - doxorubicin - methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysisPing Wu, Faith E Davies, Clive Horton, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2011
Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysisParameswaran Anoop, Bronwen E Shaw, Unell Riley, et al.
Contemporary Clinical Trials|July 27, 2021
The mobile assistance for regulating smoking (MARS) micro-randomized trial design protocolInbal Nahum-Shani, Lindsey N Potter, Cho Y Lam, et al.
The Journal of Infectious Diseases|March 7, 2006
Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosisDuncan A Clark, Elisabeth P Nacheva, Hoe Nam Leong, et al.
Clinical Transplantation|January 3, 2013
High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHDFiona L Dignan, Mike N Potter, Mark E Ethell, et al.
Oncogene|August 23, 2006
Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cellsB M Pickering, S de Mel, M Lee, et al.
British Journal of Haematology|May 27, 2005
Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatmentsCaroline L Alvares, Faith E Davies, Clive Horton, et al.
British Journal of Haematology|March 9, 2011
Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host diseaseBronwen E Shaw, Jane F Apperley, Nigel H Russell, et al.
Bone Marrow Transplantation|January 16, 2013
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation studyP G Medd, A J Peniket, T J Littlewood, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 24, 2007
N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacyCécile Béguin, David N Potter, Jennifer A Dinieri, et al.
Pageof 26